The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: On Nov. 20, the FDA approved an abbreviated new drug application for succinylcholine chloride injection USP 200 mg/10 mL, which ...
from Google Alert - health https://ift.tt/39diFDI
via IFTTT
0 comments:
Post a Comment